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The vertebrate inner ear consists of a complex labyrinth of epithelial cells that is surrounded by a bony capsule. The
molecular mechanisms coordinating the development of the membranous and bony labyrinths are largely unknown.
Previously, using avian retrovirus encoding Noggin (RCAS-Noggin) or beads soaked with Noggin protein, we have shown
that bone morphogenetic proteins (BMPs) are important for the development of the otic epithelium in the chicken inner ear.
Here, using two additional recombinant avian retroviruses, dominant negative and constitutively active forms of BMP
receptors IB (BMPRIB), we show that BMPs, possibly acting through BMPRIB, are important for otic capsule formation. We
also show that Bmp2 is strongly expressed in the prospective semicircular canals starting from the canal outpouch stage,
suggesting that BMP2 plays an important role in canal formation. In addition, by correlating expression patterns of Bmps,
their receptors, and localization of phosphorylated R-Smad (phospho R-Smad) immunoreactivity, an indicator of BMP
activation, we show that BMPs emanating from the otic epithelium influence chondrogenesis of the otic capsule including
the cartilage surrounding the semicircular canals. © 2002 Elsevier Science (USA)INTRODUCTION
The vertebrate inner ear consists of a membranous and
bony labyrinth. The membranous labyrinth is made up of
epithelial cells derived from the otic vesicle, whereas the
bony labyrinth is derived from surrounding mesenchymal
cells of mesodermal or neural crest origin. In a mature inner
ear, the membranous and bony labyrinths are separated by
a space filled with perilymph, a fluid that is similar in
composition to cerebral spinal fluid. At maturity, the inner
border of the otic capsule largely follows the intricate
contour of the membranous labyrinth. Several lines of
evidence suggest that the formation of the two labyrinths
are coordinated during development. Brn-4, a POU domain-
containing transcription factor, is expressed in the mesen-
chyme surrounding the otic vesicle but not in the otic
epithelial cells. Knockout of Brn-4 in mice has been shown
to have morphogenetic defects in the membranous laby-
rinth, providing strong molecular evidence for mesenchyme
1 To whom correspondence should be addressed. Fax: (301) 402-380signaling to the otic epithelium (Phippard et al., 1999).
Analysis of double knockout mice of Prx1 and 2 implicated
these genes in mediating mesenchyme-to-epithelial inter-
action in the inner ear, even though Prx2 is expressed in
both tissues (ten Berge et al., 1998). Furthermore, studies
using otic mesenchymal cultures suggest that factors in-
cluding TGF-1 and FGFs are released by otic epithelial
cells and mediate otic chondrocyte differentiation (Frenz
and Liu, 1998; Frenz et al., 1994).
Bone morphogenetic proteins (BMPs) belong to the TGF
superfamily and are involved in a wide range of cellular
functions including epithelial–mesenchymal interactions.
For example, Bmp4 expression in early oral epithelium
specifies tooth identity by directing specific odotogenic
gene expression in underlying mesenchymal cells (Tucker
et al., 1998). Also, Bmp4 expression in the surface ectoderm
is required for the intermediate mesoderm to differentiate
into epithelial tissue for nephric duct formation (Obara-
Ishihara et al., 1999).
BMPs transduce their signals by binding to and inducing
the dimerization of different type I and type II serine/
threonine kinase receptors at the plasma membrane that5475. E-mail: wud@nidcd.nih.gov.
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result in phosphorylation of the type I receptors. Two
primary type I receptors for BMPs, BMPRIA and -B, have
been identified, and they have been shown to be activated
by BMP2, -4, and -7 as well as heterodimers of these ligands
(Heldin et al., 1997; ten Dijke et al., 2000; Israel et al.,
1996). The phosporylation of the type I receptors, in turn,
results in C-terminal phosphorylation of specific receptor-
regulated Smad proteins (R-Smad1, -5, and -8) that form
oligomer with Smad4 (C-Smad) and then relay signals to the
nucleus to activate transcription (Kawabata et al., 1998).
The activities of R-Smads at both the cytoplasmic and
nuclear levels are regulated by multiple proteins, suggesting
the importance of R-Smads as signal integrators (for review,
see Gouedard et al., 2000; Heldin et al., 1997; ten Dijke et
al., 2000; von Bubnoff and Cho, 2001).
BMPs are diffusible molecules that are released by a
variety of source cells and either act autonomously or
influence neighboring target cells. The effective extracellu-
lar concentration of BMPs reaching a target can be regulated
by a number of mechanisms, including inactivation by
antagonists such as Noggin, Chordin, and DAN (Dale and
Jones, 1999; Pearce et al., 1999; Sasai and De Robertis,
1997). In Xenopus gastrula, the antagonistic action of Nog-
gin toward BMP4 plays an important role in establishing
the dorsal–ventral axis of the embryo (for review, see Dale
and Jones, 1999; Sasai and De Robertis, 1997). Similarly, in
developing tissues of other species, Bmp- and Noggin-
expressing cells are often found in adjacent domains, indi-
cating that the antagonism of BMPs by Noggin is a widely
used mechanism for modulating BMP signaling during
embryogenesis (Brunet et al., 1998; Marcelle et al., 1997;
McMahon et al., 1998; Reshef et al., 1998).
The role of BMPs in the development of chicken inner ear
was demonstrated by blocking BMPs activity in vivo using
various approaches, including infecting with avian retrovi-
rus encoding Noggin and delivering exogenous Noggin
protein using beads or genetically engineered cells (Chang
et al., 1999; Gerlach et al., 2000). These types of perturba-
tion experiments consistently yielded inner ears with trun-
cated semicircular canals and malformed sensory organs.
Here, we show that, in addition to the reported membra-
nous defects, Noggin treatment also affected otic capsule
development. The loss in cartilage capsule was always
associated with loss of membranous epithelium. To deter-
mine whether Noggin has a primary effect on otic capsular
development, we compared the phenotype obtained from
infecting inner ears with avian retroviruses encoding con-
stitutively active or dominant negative BMP type IB recep-
tor (RCAS-caBMPRIB, -dnBMPRIB). Our results showed
that ectopic expression of the constitutively active form of
BMPRIB receptors caused cartilage overgrowth, whereas the
dominant negative form of the receptor caused loss of
cartilage in the otic capsule. The correlation between Bmp
expression patterns and phospho R-Smad immunoreactiv-
ity, an indicator of BMP-activated cells, suggests that BMPs




Fertilized chicken eggs (Spafas) were incubated at 38°C, and
embryos were staged according to Hamburger and Hamilton (1951).
Embryos for in situ hybridization and immunostaining were fixed
in 4% paraformaldehyde at 4°C overnight; whereas embryos for
paint-fill were fixed in Bodian fixative and processed as described
(Bissonnette and Fekete, 1996).
In Situ Hybridization
In situ hybridization experiments were carried out with cryosec-
tions as described (Wu and Oh, 1996). In situ hybridization results
presented from each stage were representatives of at least three
experiments unless specified otherwise. Riboprobes for chicken
Bmp4, Bmp7, Msx1, and Noggin were prepared as described (Chang
et al., 1999). Riboprobes for chicken Bmp2 (Laufer et al., 1994),
BMPRIB (Zou et al., 1997), were prepared as described. A 3.1-kb
chicken Smad1 cDNA (clone M28) and a 2.9-kb chicken Smad5
cDNA (clone M39) were used to generate respective riboprobes. A
chicken Smad8 riboprobe was prepared by using a PCR product as
template, generated using E5 chicken embryo cDNA and forward
5-gaactccaggaagccacaatgggcggtca, and reverse 5-cttgcagacagtggct-
gggtggaaaccatg primers.
Retroviral Infection and Noggin Bead Implantation
Construction of avian retroviruses encoding dominant negative
and constitutively active forms of BMPRIB were described previ-
ously (Zou et al., 1997). Recombinant retroviruses were prepared
according to procedures described in Morgan and Fekete (1996), and
titers of 1  108–9 units/ml were obtained. Viruses were injected
into either the lumen of otocysts or surrounding mesenchyme as
described in Results. Injections of RCAS alone yielded normal
inner ears (data not shown). The monoclonal anti-gag antibody
(3C2) was used to detect the extent of viral infection (Chang et al.,
1999).
Noggin bead implantations were performed as described in
Chang et al. (1999), except that a recombinant mouse Noggin-Fc
chimeric protein (R&D Systems 719-NG) was used. Similar results
as described in Chang et al. (1999) were obtained by using this
commercially prepared reagent.
Histological Staining and Immunocytochemistry
Alcian blue staining of cartilage was performed by fixing em-
bryos overnight in Bodian fixative, followed by overnight staining
with 1% Alcian blue in 75% ethanol. Specimens were destained
with 75% ethanol in 0.1 N HCl, followed by dehydration and
clearing in methyl salicylate. Some specimens were further pro-
cessed for paint-fill injection after Alcian blue staining.
Phospho Smad1 (PS1) antibody was raised against a phosphory-
lated synthetic peptide (spp) (KKK-NPIS[Sp]V[Sp]), resembling type
I receptor phosphorylated sequences in the C-terminal end of
mouse Smad1, -5, and -8 as described (Kretzschmar et al., 1997;
Persson et al., 1997). This peptide sequence is conserved among
chicken and human Smad1 and -5. Immunostaining with PS1
antibody (1:2000 dilution) was carried out by using biotinylated
anti-rabbit IgG and alkaline phosphatase-conjugated streptavidin
immunochemistry procedure and BCIP/NBT for detection. In
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antibody-blocking experiments with PS1, either 10 mol/ml of
cognate phosphorylated synthetic peptide (spp) or an equivalent
amount of nonphosphorylated peptide (np) was preincubated with
PS1 antibody for 2 h at room temperature before using for immu-
nostaining. The blocking experiment was repeated with tissues
from five different embryonic stages, and similar results were
obtained. The specificity of PS1 antibody was verified in a Western
blot analysis using otic capsule tissues from RCAS-caBMPRIB-
infected ears. A major band of about 60 kDa, which approximates
the estimated molecular weight of chicken Smad1 and -5, was
identified. This immunoreactive band recognized by PS1 antibody
was seen when the antibody was preblocked with the np but not by
the spp (data not shown). BrdU labeling and detection were carried
out by using a cell proliferation kit (Amersham).
RESULTS
Expression of Bmp2, -4, and -7 during Canal
Development
Three semicircular canals are present in the chicken
inner ear: anterior, posterior, and lateral. The anterior and
posterior canals form from a common vertical epithelial
outpouch in the dorsal half of the otocyst, and the lateral
canal forms from a horizontal outpouch (Fig. 1A; Bisson-
nette and Fekete, 1996). These outpouches are evident
starting at E3.5 to E4. By E5, the opposing epithelia in the
center region of each presumptive canal start to come
together, fuse, and resorb, leaving behind a tube-shaped
canal. This process of canal formation is completed by E7,
even though the canals continue to increase in size until
E16 (Bissonnette and Fekete, 1996). Here, we examined the
temporal and spatial patterns of expression of Bmp2, -4, and
-7 during these different stages of canal development (Figs.
1 and 2).
Unlike Bmp4 and -7, Bmp2 is not expressed in the otic
cup or newly formed otocyst (Chang et al., 1999). However,
starting at E3.5, Bmp2 was expressed in the canal outpouch.
Its expression was not detected in the center of the canal
outpouch, which is fated to be resorbed, but was detected
toward the ends of the canal outpouch, in regions that are
destined to form the canals (Figs. 1B and 2C). Once the
canals were formed by E7, Bmp2 expression displayed a
similar pattern as in younger ages although with more
robust expression in the outer rim of the canal (Fig. 1E).
Bmp2 was also expressed at a low level in the endolym-
phatic duct, but there was little or no expression in mesen-
chyme surrounding the canal pouch at E5 (Fig. 1B). At later
stages, Bmp2 was also expressed in the otic capsule (see
below).
Bmp7 is broadly expressed in both sensory and nonsen-
sory regions of the inner ear initially, and gradually its
expression diminishes in the vestibular sensory organs but
remains high in nonsensory components of the inner ear as
well as the sensory region of the cochlear duct (Oh et al.,
1996). In the vertical canal pouch, the Bmp7 expression
domain encompassed but was broader than that of Bmp2
(Figs. 1B, 1C, 2C, and 2D, arrows). Once the canals were
formed, Bmp7 expression remained high on both sides of
the canals (Fig. 1F). Bmp7 was also expressed in the en-
dolymphatic duct and in the mesenchyme surrounding the
canal pouch (Fig. 1C; Oh et al., 1996).
Previously, we have shown that Bmp4 is expressed in all
the presumptive sensory organs of the chicken inner ear
(Cole et al., 2000; Wu and Oh, 1996) including the cristae,
the sensory organs for the semicircular canals. It is also
expressed weakly in the middle region of the canal pouch,
but is highly expressed in mesenchyme surrounding that
region (Fig. 1D; also see Fig. 6C in Oh et al., 1996). Most of
the epithelial cells in the middle of the canal pouch undergo
resorption starting at E6. Once the canals are formed, Bmp4
expression is restricted to two small regions that flank the
Bmp2-positive domain (see Fig. 7D in Chang et al., 1999).
Expression of BMPRI and R-Smads in Canal
Pouches and Semicircular Canals
In order to identify the cells that might respond to BMPs
and gain insight into the possible roles of these ligands in
mediating epithelial–mesenchymal interactions in the in-
ner ear, we compared the gene expression patterns of BMPs
with their receptors, BMPRIA and -B, as well as their
intracellular transducers, Smad1, -5, and -8. At E6, BMPRIA
was ubiquitously expressed in otic epithelium and sur-
rounding mesenchyme (Fig. 2A), similar to what was re-
ported for mouse inner ear (Dewulf et al., 1995). BMPRIA
expression was detectable at E3.5 (data not shown); BM-
PRIB expression, however, was not detected until E6. In the
canal pouch, BMPRIB expression was highest in the mes-
enchyme; hybridization signal was found in close associa-
tion with epithelia at the two ends of the canal pouch but
not with the epithelia in the central region of the canal
pouch (Fig. 2B, black double arrow). The two ends of the
canal epithelial were also weakly positive for BMPRIB
expression (Fig. 2B).
Smad1, -5, and -8 are thought to be the intracellular
transducers of BMP2, -4, and -7 signaling (for review, see ten
Dijke et al., 2000). Figures 2C–2F are adjacent sections of a
vertical canal pouch at E6 probed for Bmp2, Bmp7, Smad1,
and Smad5, respectively. At this age, Bmp7 expression was
higher toward the ends of the canal pouch, but its expres-
sion domain was broader than that of Bmp2 (Figs. 2C and
2D, arrows). Smad1 was ubiquitously expressed in the
entire canal pouch epithelium at E6, but expression in the
surrounding mesenchyme was low (Fig. 2E). Later, in canal
development, Smad1 expression was also detected in the
otic capsule. In contrast, Smad5 expression was detected in
mesenchymal cells that were bordering the canal pouch
epithelium but was weak in the canal epithelia (Fig. 2F).
Smad8 hybridization signal was not detected in the otic
epithelium or adjacent mesenchyme at either E6 or E9 (data
not shown).
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Phospho Smad1/5/8 in Canal Pouches and
Semicircular Canals
Binding of BMP2/4/7 to their receptors, BMPRIA or -B,
results in phosphorylation of the C termini of Smad1, -5,
and -8 and their subsequent translocation into the nucleus
where they activate transcription of target genes (Massague,
1998; ten Dijke et al., 2000; Xiao et al., 2001). Our gene
expression data showed a good correlation between the
locations of cells synthesizing BMPs and cells expressing
BMP receptors or intracellular transducers. To further ex-
amine whether cells expressing Smad1 and -5 were actively
responding to BMP signaling, we performed immunostain-
ing on inner ears ranging in age from E4 to E11 using PS1, an
antibody that specifically recognizes the activated, phos-
phorylated forms of Smad1, -5, and -8.
Figures 2G–2J illustrate the pattern of PS1 immunostain-
ing in the canal pouch at E6.5. PS1 immunostaining was
present in both the epithelium and mesenchyme (Fig. 2G).
This staining pattern was abolished when the PS1 antibody
was preblocked with the phosphorylated peptide (Fig. 2H),
but not with the nonphosphorylated peptide (Fig. 2G),
FIG. 1. Bmp expression patterns in canal pouches and canals at E5 and E7. (A) A schematic diagram illustrating the approximate time line
of canal development in chicken. Dotted lines represent the levels of sections for E5 (B–D) and E7 (E, F), respectively. The endolymphatic
duct/sac and cochlear duct regions in the diagram were shaded as gray and dark gray, respectively. Gene expression patterns of Bmp2 (B),
Bmp7 (C), and Bmp4 (D) in canal pouch at E5. (B) and (C) are 12-m adjacent sections. (B) Bmp2 expression is restricted to both ends of the
canal pouch as well as the endolymphatic duct. (C) Bmp7 is expressed in the canal pouch with higher concentration at both ends of the
pouch as well as within the endolymphatic duct and mesenchyme. (D) Bmp4 is expressed weakly in the middle region of the canal pouch
but strongly in the adjacent mesenchyme. The Bmp4 expression in the canal pouch and mesenchyme appear complementary to that of
Bmp2. (E) and (F) are 12-m adjacent sections of the anterior semicircular canal probed for Bmp2 and Bmp7 transcripts, respectively. Scale
bar in (B) applies to (C) and (D); scale bar in (E) applies to (F). Black arrows in (C), (E), and (F) point to the outside margin of the canal pouch
or canal. White arrows in (C) point toward the middle region of the canal pouch. Abbreviations: ac, anterior canal; vp, vertical outpouch;
hp, horizontal outpouch; rr, resorption region. Orientations: A, anterior; D, dorsal; L, lateral.
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confirming the binding specificity of this antibody. In the
canal pouch, PS1 immunostaining was strong at both ends
of the canal pouch (Fig. 2G, large black arrows), similar to
the expression patterns of Bmp2, Bmp7 (Figs. 1B, 1C, and
2C), and Smad1 in these regions (Figs. 2E). PS1 staining in
these regions was evident at E4 and continued until at least
E11 in the outer rim of the formed canals (see Fig. 8C). Some
positive cells were also present in the prospective common
crus (Fig. 2G, black arrowhead) and resorption regions of the
canal pouch (Figs. 2G and 2J, small black arrows). Interest-
ingly, despite the expression of both Bmp2 and -7 in the
endolymphatic duct, phospho Smad1/5/8 was not detected
in this tissue (Fig. 2I).
Three regions of otic mesenchyme showed high PS1
immunostaining in cell nuclei, indicative of active BMP
signaling: (1) regions immediately adjacent to the ends of
the canal pouch (Figs. 2G and 2J, white arrows), (2) an area
by the middle of canal pouch not immediate adjacent to the
canal epithelium (Fig. 2G, large white arrowheads; also a
BMPRIB-positive region, Fig. 2B), and (3) a restricted do-
main between the canal pouch and the endolymphatic duct
and sac (Figs. 2G and 2I, small white arrowheads).
RCAS-Noggin Induced Phenotypes in Both the Otic
Capsule and Semicircular Canals
Previously, we showed that antagonizing the action of
BMPs by the exogenous expression of Noggin in the inner
ear causes otic epithelial defects, with the most prevalent
defect being the truncation of semicircular canals (Chang et
al., 1999). Here, we demonstrate that, in addition to these
epithelial defects, exogenous Noggin expression adversely
affected otic capsular cartilage formation. Alcian blue stain-
ing of normal inner ears demonstrated that otic capsular
cartilage was only apparent in some regions at E7 but found
in all regions of the inner ear by E9 (Fig. 3B, E9). In contrast,
RCAS-Noggin infection of the otocyst at E3 caused loss of
the otic capsular cartilage shown at E9 (Figs. 3C and 3D).
Double-labeling of infected inner ears with paint-fill and
Alcian blue staining indicates that regions of capsular and
canal loss were spatially similar (Fig. 3D; n  21). Two
interpretations are plausible for this result. Since Noggin is
FIG. 2. Expression of Bmps, BMPRIs, R-Smads in canal pouch.
Cryosections of the canal pouch at E6 were probed for BMPRIA (A),
BMPRIB (B), Bmp2 (C), Bmp7 (D), Smad1 (E), and Smad5 (F). (A)
BMPRIA is ubiquitously expressed in the epithelium and mesen-
chyme. (B) BMPRIB is expressed in mesenchymal cells adjacent to
both ends of the canal epithelium. However, BMPRIB-positive
mesenchymal cells and the central region of the canal pouch are
not in direct contact (double arrow). (C–F) are 12-m adjacent
sections. (C) Bmp2 remains positive at the two ends of the canal
pouch, whereas Bmp7 expression diminishes in those regions (D).
In the middle of the canal pouch, Bmp7 expression domain remains
broader than that of Bmp2 (arrows). (E) Smad1 is ubiquitously
expressed in the otic mesenchyme and canal pouch. (F) Mesenchy-
mal Smad5 expression is adjacent to the canal pouch. (G–J) are
sections of canal pouches at E6.5 stained with PS1 antibody that
was preblocked with nonphosphorylated peptide (np, G), or phos-
phorylated peptide (spp, H). (I and J) are higher power magnifica-
tions of the endolymphatic duct and canal pouch regions boxed in
(G), respectively. Strong mesenchymal PS1 staining by the en-
dolymphatic region (small white arrowheads in G and I), regions
adjacent to the ends of canal pouch (white arrows in G and J), and
a region not immediate adjacent to the canal pouch (large white
arrowheads, G). Strong epithelial PS1 staining at the ends of the
canal pouch (large black arrows, G and J). Some cells with strong
PS1 staining in resorption areas (small black arrows, G and J) and
the prospective common crus (black arrowhead, G). Scale bar in (C)
applies to (D); scale bar in (E) applies to (F); scale bar in (J) applies to
(I). Abbreviation: ed, endolymphatic duct/sac. Orientations: A,
Anterior; L, Lateral.
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FIG. 3. Membranous and capsular phenotypes of RCAS-Noggin infected inner ears at E9. (A) a normal, paint-filled inner ear. A crista, the
sensory organ for each semicircular canal, is housed within each ampulla. (B–D) Alcian blue staining of the otic capsule. (B) Normal inner
ear. (C) RCAS-Noggin-infected inner ear at E3 showing loss of cartilage by E9. (D) The lumen of the membranous labyrinth in (C) paint-filled
after Alcian blue staining (n  21), showing regions of otic epithelial and capsular loss are similar. Red asterisk indicates the location of
the anterior canal. Abbreviations: AA, anterior ampulla; ac, anterior semicircular canal; CD, cochlear duct; cc, common crus; ed/s,
endolymphatic duct/sac; LA, lateral ampulla; lc, lateral semicircular canal; PA, posterior ampulla; pc, posterior semicircular canal; s,
saccule. Scale bar in (B) applies to (C, D). Orientations: D, dorsal; A, anterior.
FIG. 4. RCAS-dnBMPRIB- and RCAS-caBMPRIB-infected inner ears. RCAS-dnBMPRIB was injected to either the lumen (A, B) or
surrounding mesenchyme (C) of chicken inner ears at E2–E2.5, and harvested at E9. (A) Loss of cartilage in the peri-canal regions (empty
blue circles). Red asterisk indicates the position of the posterior canal. (B) Paint-filled inner ear that was stained with Alcian blue. (C) Inner
ears with mesenchymal injection show a greater loss of cartilage than those with virus injected to the lumen (A, B). Red arrowheads in (A)
and (C) show the region of the otic capsule that was less affected. (D–F) RCAS-caBMPRIB was injected to the lumen of inner ears at E2.5
and harvested at E9. (D) An infected inner ear stained with Alcian blue. Red asterisk indicates the canal region and the red arrowhead shows
the boundary of the capsule. (E) An infected inner ear double labeled with paint and Alcian blue. Red arrowheads point to the outline of
the otic capsule. Small arrowhead points to the mandibular cartilage. (F) A RCAS-caBMPRIB infected, paint-filled inner ear. Red arrows
point to defects in the otic epithelium. Abbreviations: ac, anterior canal; ed/s, endolymphatic duct/sac. Scale bar in (A) applies to (B–F).
Orientations: A, Anterior; D, Dorsal.
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a diffusible ligand, it could affect otic epithelium and
cartilage independently. Alternatively, the loss of otic cap-
sule may be a secondary effect, occurring as a result of loss
of otic epithelia.
Inner Ear Phenotypes Associated with Exogeneous
Expression of Dominant Negative and
Constitutively Active Forms of BMPRIB
In order to define the role(s) of the BMP pathways in inner
ear development, we infected inner ears with RCAS viruses
encoding dominant negative (dn) and constitutively active
(ca) forms of BMPRIB. The spread of viral infection was
determined by immunostaining with 3C2, an antibody
raised against the viral gag protein. In our study, we
observed that the spread of various recombinant RCAS
viruses was highly efficient in the mesenchyme, but was
poor in otic epithelia (see examples below).
Injection of RCAS-dnBMPRIB into the lumen of the inner
ear at E2.5 caused loss of capsular cartilage that was clearly
evident in E9 harvested inner ears (Fig. 4A, blue circles; Fig.
4B, 10 out of 12 infected specimens). Loss of cartilage was
severe in the peri-canal and edge regions but was less severe
in the central region of the capsule (Figs. 4A–4C, red
arrowhead). A similar phenotype was obtained by injecting
virus directly into the mesenchyme, and earlier injections
resulted in more severe phenotypes (Fig. 4C; 16 out of 19
specimens). Consistent with the nature of the viral infec-
tion, no epithelial phenotype was observed in RCAS-
dnBMPRIB-infected inner ears (Figs. 4B and 4C; n  12),
whereas mesenchyme-derived otic cartilage was severely
affected. These results are also consistent with Noggin
antagonism experiments and suggest that BMPs are critical
for otic cartilage formation and that blockage of the BMP
pathways result in the loss of cartilage.
In contrast, overactivation of BMP pathways by the
exogenous expression of a constitutively active BMP recep-
tor resulted in cartilage overgrowth. Injection of RCAS-
caBMPRIB virus into the lumen or adjacent mesenchyme of
the inner ear at E2.5 resulted in overgrowth of the capsular
cartilage (Fig. 4D; n  34). However, despite the strong
Alcian blue staining of RCAS-caBMPRIB-infected ears at
E9, there was no indication of premature initiation of
cartilage formation before E7 (data not shown, n  8). Also,
no ectopic cartilage nodule was observed outside the en-
larged otic capsule.
In addition to the overgrowth of cartilage, severe epithelial
defects were observed in RCAS-caBMPRIB-infected ears (Fig.
4E; 12 out of 14 specimens), including loss of semicircular
canals, common crus, ampullae, saccule, and deformed co-
chlear duct (compare Fig. 3A with Figs. 5E and 5F). In contrast,
the endolymphatic duct was not affected. Similar to the
RCAS-dnBMPRIB infected ears, a majority of the viral infec-
tion was only detected in the mesenchyme (see below).
FIG. 5. Gene expression in RCAS-caBMPRIB-infected inner ears. (A–C) Wildtype inner ears. (D–F) RCAS-caBMPRIB-infected ears. Gene
expression patterns of Bmp2 (A and D), Smad1 (B and E), and Msx1 (C and F) are compared between wildtype and infected inner ears at E9.
Bmp2 and Smad1 gene expression patterns did not change in infected ears. However, in infected inner ears (F), Msx1 expression is
downregulated in the canal epithelium (black arrows) but upregulated in the mesenchyme (white arrowhead; n  4). White arrow in each
panel points toward the outer margin of the canal. Scale bar in (C) applies to (A–F).
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Down-Regulation of Msx1 in Semicircular Canal in
RCAS-caBMPRIB Infected Ears
The epithelial phenotypes elicited by the activation of
the BMP pathways raised an interesting paradox. Various
approaches of using Noggin to block BMP pathways suggest
that BMPs are important for canal formation and that the
antagonism of BMP activity results in canal truncations.
From these results, one might expect that constitutive
activation of BMP receptors would result in not only
cartilage overgrowth but also canal overgrowth. Instead,
RCAS-caBMPRIB infected ears showed canal truncations
similar to those induced by exogenous expression of Nog-
gin. The poor RCAS-caBMPRIB infection in otic epithelial
cells themselves indicated that the canal phenotype was an
indirect effect and could be due to physical occulsion
caused by overgrowth of the surrounding cartilage since
most infected inner ears did not show any gross membra-
nous defects until E8–E9.
A detailed examination of the gene expressions in canals
of RCAS-caBMPRIB-infected inner ears, prior to morpho-
logical changes, was performed by using a panel of known
canal markers, including SOHo-1, Bmps, and Msx1 (Kier-
nan et al., 1997; Wu and Oh, 1996). With the exception of
Msx1, there was little change in the levels of expression of
the markers tested. Figure 5 illustrates that the levels of
Bmp2 and Smad1 expression in canals of RCAS-caBMPRIB-
infected ears were similar to controls. Msx1, however, a
gene that is in some cases transcriptionally controlled by
Bmp4, was downregulated in otic epithelia (Figs. 5C and 5F,
black arrows) and was upregulated in the otic capsular
region (Fig. 5F, white arrowhead). These results suggest that
there was a downregulation of BMP function in the otic
epithelium but an upregulation in BMP function in the otic
capsule in RCAS-caBMPRIB-infected inner ears.
Up-Regulation of Noggin in RCAS-caBMPRIB
Infected Otic Mesenchyme
The downregulation of Msx1 expression in RCAS-
caBMPRIB inner ears is reminiscent of the pattern observed
in Noggin-treated ears. This observation suggested that the
exogenous expression of activated BMP receptors may re-
sult in the overexpression of endogenous Noggin and that,
in fact, the epithelia phenotype observed in the RCAS-
caBMPRIB may be a direct consequence of Noggin overpro-
duction (Chang et al., 1999). To explore this possibility, we
examined Noggin expression in the RCAS-caBMPRIB-
infected ears.
In normal inner ears, Noggin is expressed early during
inner ear development in the mesenchyme surrounding the
otic cup (Chang et al., 1999), but is down-regulated and not
detected again in the mesenchyme until E9. At E9, Noggin
was expressed within the capsular cartilage (compare Figs.
6A and 6D with 6B and 6E), whereas Bmp2 was expressed
predominantly in the inner border of the otic capsule
surrounding the canal (Figs. 6A and 6F). In RCAS-
caBMPRIB-infected ears, upregulation of Noggin was evi-
dent as early as E6 (data not shown). By E9, Noggin was
strongly induced (compare Figs. 6B and 6E with 6H and 6J)
within the overgrown cartilage (compare Figs. 6G and 6I
with 6H and 6J), and the diameter of the canal in the
infected region was reduced (compare Figs. 6E and 6F with
6J and 6K). However, no direct compression of the canals by
overgrown cartilage was observed. Bmp2 expression in the
canal epithelium and the inner border of the otic capsule
remained unchanged in infected ears (Fig. 6K).
The viral spread in infected ears, as indicated by 3C2
staining, was excluded from the otic epithelium (Figs. 6I
and 7F). Interestingly, despite the viral infection in peri-
canal mesenchymal cells and cells beyond the borders of
the otic capsule (Fig. 6I, purple cells within the dotted red
half circle and to the left of the yellow dotted line, respec-
tively), upregulation of Noggin was only observed in in-
fected cells within the otic capsule (Fig. 6J). Peri-canal
mesenchymal cells, though infected by RCAS-caBMPRIB
based on 3C2 staining, did not show Noggin upregulation.
These peri-canal mesenchymal cells are destined to un-
dergo apoptosis later in development to create the peri-
lymphatic space between the membranous and bony laby-
rinth in a mature ear. These results suggest that ectopic
expression of the constitutively active form of the BMPRIB
receptor in the mesenchyme caused an upregulation of
Noggin expression and an overproduction of Noggin protein
that affected epithelial development.
Decreased Cell Proliferation in the Semicircular
Canals of RCAS-caBMPRIB-Infected Ears
We have previously shown using PCNA (proliferating cell
nuclear antigen) staining that a decrease in cell proliferation
is one of the immediate effects of Noggin treatment during
the canal pouch stage as well as after the canals are formed
(Chang et al., 1999). We further compared cell proliferation
in control and RCAS-caBMPRIB inner ears using BrdU
labeling. Similar to the results obtained using PCNA,
canals in wildtype embryos showed the two distinct hot
spots of BrdU labeling (Fig. 7B, red arrows; Chang et al.,
1999). In contrast, the canals adjacent to the overgrown
cartilage (Fig. 7C, asterisk) in the infected inner ears were
devoid of BrdU labeling (compare Figs. 7B and 7D, n  3).
The spread of virus in the region being examined is illus-
trated in Fig. 7E, but the otic epithelium within the infected
region was devoid of 3C2 immunostaining (Fig. 7F).
Phospho Smad1/5/8 Immunostaining in RCAS-
caBMPRIB- and -dnBMPRIB-Infected Ears
To examine whether BMP pathways, presumably due to
an upregulation of Noggin expression, were perturbed in
RCAS-caBMPRIB-infected ears, we investigated R-Smad
activation in the canal region at E6 and E11 (Fig. 8). At E6,
PS1 immunostaining at the two ends of the canal pouch
was downregulated in RCAS-caBMPRIB-infected ears (Figs.
8A and 8B, arrowhead; n  6). In contrast, PS1 staining in
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surrounding mesenchyme was upregulated in these in-
fected ears (Fig. 8B, red arrows). At E11, PS1 immunostain-
ing was observed only in the outer rim of the canal in
regions corresponding to the Bmp2 expression domain (Fig.
8C, red arrowhead, n  3). In the infected ears, PS1 staining
in the canal was absent (Figs. 8D and 8E, arrowhead), and
the size of the canal was often reduced (Fig. 8E). However,
PS1 staining was upregulated in the cartilage region (Fig.
8D; red arrows).
We also investigated PS1 staining in RCAS-dnBMPRIB-
FIG. 6. Upregulation of Noggin in the capsular cartilage of RCAS-caBMPRIB. (A–F) Normal inner ears. (G–K) RCAS-caBMPRIB-infected
ears at E9. (A, D) Alcian blue-stained sections. (G, I) Double labeled with Alcian blue and 3C2 antibody. (B, E, H, J) Sections hybridized with
a Noggin probe. (F, K) Sections hybridized with a Bmp2 probe. (A, B, and F; G, H, and K) 12-m adjacent sections. (D, E, I and J) Higher
magnifications of (A, B, G, and H), respectively. The dotted line in (C) indicates the plane of sections shown in (A) and (B). Noggin is
normally expressed within the Alcian blue-positive, capsular cartilage at this age (compare D and E). Bmp2 is expressed at the inner rim
of the capsular cartilage surrounding the canals (F). (G, I) Overgrown cartilage is indicated by the blue staining, and infected cells stained
with 3C2 antibody are in purple. No infection was observed in the canal. (H, J) Upregulation of Noggin expression within the viral infected
area. The inner and outer borders of the cartilage capsule are indicated by the dotted red and yellow lines, respectively. (K) Bmp2 expression
pattern in infected ears remains. Abbreviation: cc, common crus. Scale bar in (A) applied to (B, G, and H); scale bar in (D) applied to (E, F,
and I–K).
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infected ears at E6. Figure 8G illustrates that PS1 staining in
the mesenchyme was reduced in RCAS-dnBMPRIB-infected
ears (compare Figs. 8F and 8G, red and black arrows,
respectively, n 3), whereas PS1 staining in the epithelium
remained.
Noggin Caused a Decrease of Phospho Smad1/5/8
Staining in the Canal Pouch
In addition to previously reported results of Noggin-
induced changes in the canal pouches and canals, we
further investigated its effects on Bmp2 expression and
phospho R-Smad immunoreactivity. A Noggin-soaked bead
was implanted to the posterior canal pouch at E5 and
harvested at E6. Figures 9A and 9B illustrate that Bmp2
expression in the canal pouch was not changed in the
Noggin-treated ears. However, regions by the implantation
area showed decreased PS1 staining in both the canal pouch
and its surrounding mesenchyme (Figs. 9C–9F, black arrow-
head and red arrows, respectively; n  4). These results
further confirm that the canal truncation phenotype ob-
served in RCAS-caBMPRIB- and RCAS-Noggin-infected
ears were mechanistically similar and due to loss of BMP
function.
DISCUSSION
Role of Bmps in Otic Capsule Formation
The loss of otic cartilage in RCAS-Noggin- and
-dnBMPRIB-infected ears and the gain of cartilage in RCAS-
caBMPRIB-infected ears unequivocally demonstrate a role
of BMPs in otic capsule formation. Despite the widespread
infection of RCAS-caBMPRIB in cells surrounding the otic
epithelium, the elicited capsular phenotype seemed to be
restricted to cells already committed to the chondrogenic
pathway. RCAS-caBMPRIB infection did not appear to have
an effect on cells in the peri-canal region that were destined
to undergo apoptosis, or cells that were located beyond
the otic capsule. Most likely, the mesenchymal cells that
were perturbed by ectopic expressions of altered forms of
BMPRIB were cells that endogenously express BMPRIB and
were committed to the chondrogenic pathway (Fig. 10).
RCAS-caBMPRIB infection might cause an increase in
proliferation of prechondrogenic cells but did not induce
premature chondrogenesis. Taken together, our interpreta-
tion of these results is that BMPs function to expand the
prechondrogenic population through activating BMPRIB
during normal development. Activated BMPRIB, in turn,
results in induction of Noggin expression that modulates
the level of available BMPs and controls the size of the
chondrogenic population. Our results are also consistent
with the findings that proliferation of prechondrogenic cells
and chondrocyte differentiation in digits are impaired in
BMPRIB/ mice (Yi et al., 2000).
In mouse limbs, GDF5 is thought to be one of the main
ligands for activating BMPRIB (Baur et al., 2000; Yi et al.,
2000). In the developing inner ear, however, Gdf5 hybrid-
ization signal was not detected between E3 and E7 (data not
shown) suggesting GDF5 may not play an essential role in
otic capsule formation. In contrast, based on gene expres-
sion patterns, BMPs are good candidates for activating
BMPRIB during otic chondrogenesis. Depending on their
positions and time of differentiation, cells might be acti-
vated by various forms of BMPs. For example, at early
stages, mesenchyme surrounding the central region of the
canal pouch might respond to homo- or heterodimers of
BMP4 and -7, whereas peri-canal mesenchyme might re-
spond to BMP2 and/or BMP7 emanating from the epithe-
lium (Fig. 10; and see Discussion below). At later stages, the
expression of Bmp2 in the inner border of the otic capsule
could be the primary BMPs influencing otic chondrogen-
esis. Our gene expression pattern and phenotypic analyses
indicate that the development of the otic capsule is highly
dynamic, and will be further addressed in more detail
separately (W.C., unpublished observations).
Role of BMPs in Canal Formation
Previously, we demonstrated that Noggin treatment af-
fected canal development at multiple stages. Ectopic ex-
pression of or treatment with Noggin at early stages causes
FIG. 7. Loss of epithelial proliferation in RCAS-caBMPRIB-infected ears at E8. (A–D) Paraffin sections triple-labeled with Alcian blue,
Hematoxylin staining, and anti-BrdU antibodies. (E, F) Sections double-labeled with Alcian blue and 3C2 immunostaining. (A, B) Wildtype
controls. (C–F) RCAS-caBMPRIB-infected ears. (B, D, F) Higher power magnifications of (A, C, and E), respectively. (B) Two zones of
proliferation are present in normal canal epithelium (red arrows). (D) RCAS-caBMPRIB-infected ears have smaller canals that lack BrdU
labeling. Green asterisk in (C) indicates overgrown cartilage. (E, F) Adjacent sections of (C, D). The dark purple cells in (E) and (F) represent
cells infected with RCAS-caBMPRIB. Note the absence of purple cells within the otic epithelium. Scale bar in (A) applies to (C) and (E); scale
bar in (B) applies to (D) and (F). Orientations: A, anterior; L, lateral.
FIG. 8. PS1 immunostaining in RCAS-caBMPRIB- and -dnBMPRIB-infected ears. (A) Wildtype and (B) RCAS-caBMPRIB-infected canal
pouches at E6. Relative to the wildtype, PS1 staining in RCAS-caBMPRIB-infected ear is more intense in the cartilage (red arrows) but less
intense in the canal epithelium (arrowhead). (C) Wildtype and (D, E) RCAS-caBMPRIB-infected canals at E11. PS1 staining of the canal is
lost in the infected inner ears (red arrowheads) but it is more intense than wildtype in the cartilage (double red arrows). (F) Wildtype and
(G) RCAS-dnBMPRIB-infected canal pouch at E6. Mesenchymal PS1 staining is decreased relative to wildtype (red arrows) in dnBMPRIB
infected inner ear (black arrows). Abbreviations: hp, horizontal pouch; ed, endolymphatic duct.
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defects in canal pouch outgrowth and canal truncation.
Noggin treatment shortly after canal formation also re-
sulted in truncation of the canal, suggesting that there is a
continual requirement of BMPs in maintaining these struc-
tures (Chang et al., 1999). Even though we interpreted these
phenotypes to be caused by a lack of BMPs, there was a
paradoxical upregulation of endogenous Bmp4 in Noggin-
treated canals. However, the downregulation of Msx1 ex-
pression reported previously (Chang et al., 1999) and the
reduction of phospho R-Smad immunostaining reported
here (Fig. 9) confirmed our previous interpretation that the
canal phenotype is due to a lack of BMP signaling, despite
the upregulation of Bmp4 expression. Evidence of Noggin
and BMPs mutually regulating each other in vivo has been
documented in other tissues as well (Capdevila and John-
son, 1998; Chang et al., 1999; Nifuji and Noda, 1999; Pathi
et al., 1999; Pizette and Niswander, 2000; Varley et al.,
1998). This lends further support to the importance of a
tightly regulated equilibrium between BMPs and Noggin
necessary for normal development (Brunet et al., 1998;
McMahon et al., 1998).
Another example of interplay between BMP and Noggin
is the upregulation of Noggin in the mesenchyme as a result
of RCAS-caBMPRIB infection. The result of which has an
adverse effect on canal epithelium. The decrease in BrdU
labeling (Fig. 7D), the downregulation of Msx1 (Fig. 5F), and
the reduction of phospho R-Smad immunoreactivity (Figs.
8D and 8E), all supported a loss of BMP signaling in the
canal as a result of endogenous Noggin upregulation. To-
gether, the results of the ectopic expression Noggin and the
RCAS-caBMPRIB infections demonstrated the importance
of BMPs in canal formation.
Contrary to our earlier belief that BMP4 functions in the
inner ear are the primary ones that were being perturbed
with ectopic Noggin treatment (Chang et al., 1999), the
strong and continual expression of Bmp2 in the canals
starting from the canal pouch stage makes Bmp2 a primary
candidate for mediating canal formation (Fig. 10). Little or
no Bmp2 hybridization signal was detected in the presump-
tive sensory region (W.C., unpublished observation),
whereas Bmp4 was highly expressed here. Therefore, Bmp4
remains a strong candidate for mediating sensory organ
development. Furthermore, the presence of Bmp4 and -7 is
expressed in the middle region of the canal pouch and
surrounding mesenchyme, and BMPRIA and Smad5 have
overlapping expression in those regions. In both Noggin-
treated and RCAS-caBMPRIB-infected ears, defective com-
mon cruses were also observed (Figs. 4E and 4F; Chang et
al., 1999). This suggests that BMPs also play a role in the
resorption process and/or the formation of the common
crus.
Epithelial and Mesenchymal Interaction
The collective expression patterns of Bmps, their recep-
tors, and downstream transducers (R-Smads) indicate that
BMPs have a direct role in the development of both the
epithelial and mesechymal portions of the inner ear. It is
unclear, however, whether BMPs also play a role in orches-
trating epithelial–mesenchymal interactions in the inner
ear, or each tissue respond to BMPs generated within its
own tissue.
Expression patterns in two particular regions of the
developing inner ear suggest that epithelial–mesenchymal
interaction are being mediated by BMPs. One is the mesen-
chymal region surrounding the two ends of the canal pouch.
In these regions, Bmp2 and a low level of Bmp7 were
expressed in the canal pouch but there was little or no Bmp
hybridization signal detected in the surrounding mesen-
chyme (Figs. 1B, 1C, 2C, and 2D). However, the BMP
pathway appeared to be activated in mesenchymal cells
based on the strong phospho R-Smad immunostaining (Figs.
2G and 2J). Therefore, the mesenchymal cells in that region
could be responding to BMPs released by the epithelium.
The Noggin implantation and RCAS-caBMPRIB infection
experiments clearly demonstrated that secreted proteins
could diffuse between the two tissues.
Another potential region for BMPs to be mediating
epithelial–mesenchymal interaction is the mesenchyme
surrounding the endolymphatic duct. There was strong
Bmp7 and a low level of Bmp2 expressions in the endolym-
phatic duct, but weak Bmp expression in the surrounding
mesenchyme (Fig. 1). Nevertheless, the strong phospho
R-Smad immunoreactivity in the mesenchyme immedi-
ately adjacent to the epithelium (Fig. 2I) suggests that those
mesenchymal cells are responding to BMPs secreted by the
endolymphatic duct. Interestingly, no phospho R-Smad
immunostaining was evident in the endolymphatic duct,
suggesting that a majority of the BMPs generated by the
epithelial cells act primarily on cells outside the epithe-
lium. This hypothesis is further supported by the fact that
the endolymphatic duct appears normal in RCAS-Noggin-
and -caBMPRIB-infected ears where the levels of BMPs are
presumably depleted. Also, despite the coexpression of
Bmps and Msx1 in the endolymphatic duct, their regulation
is independent (Fig. 1; Oh et al., 1996; Chang et al., 1999). In
this respect, the endolymphatic duct is different from
tissues such as canal, cristae, and cartilage where Msx1
expression is regulated by the BMP pathway (Chang et al.,
1999; Monsoro-Burq et al., 1996; Fig. 5).
In summary, we showed that one role of BMPs in inner
ear development could be inducing proliferation of prechon-
drogenic cells through activation of BMPRIB. We also
confirmed that BMPs play a critical role in canal develop-
ment and provided evidence that BMP2 is a key player in
this process. The role of BMPRIB in otic epithelium cannot
be addressed due to poor infection within the epithelium.
BMPRIB knockout mice are viable with skeletal defects,
and the patterning of their inner ears has not been examined
in detail (Baur et al., 2000; Yi et al., 2000). BMPRIA is
ubiquitously expressed in inner ears of both mice and
chicken, but its role in the inner ear development remains
unclear. Our preliminary results showed that injecting
RCAS-caBMPRIA to the developing inner ear also resulted
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FIG. 9. Changes in Bmp2 expression and PS1 immunostaining in the Noggin-treated inner ears. (B, D) Sections from a right inner ear that
has been implanted with a Noggin-soaked bead at E5 and harvested at E6. (A, C) Control sections from the left ear of the same specimen.
A Noggin-soaked bead was implanted close to the presumptive posterior canal region Bmp2 expression did not change in the implanted ear
(compare A and B). (E, F) Higher magnifications of (C) and (D), respectively. PS1 staining in both mesenchyme (red arrows, C–F) and epithelia
(black arrowhead) are decreased in Noggin-treated inner ears. Abbreviation: b.v., blood vessel. Scale bar in (A) applies to (B–D); scale bar in
(E) applies to (F). Orientations in (A) apply to (C); orientations in (B) apply to (D). Orientations: A, Anterior; L, Lateral; M, Medial.
FIG. 10. A schematic model illustrating the involvement of BMP signaling during the canal pouch (A) and canal (B) stages. This model is
based on results presented here and in Chang et al. (1999). The orange and purple colored areas represent regions expressing Bmp2 and
Bmp4, respectively. Hatched lines represent regions undergoing rapid proliferation. In this model, at the canal pouch stage (A), BMP2, -4,
and -7 (not shown) emanating from various regions of otic epithelium and periotic mesenchyme induce the initiation/differentiation of otic
chondrogenesis. The observation that some mesenchymal cells express BMPRIB and display phospho-Smad immunostaining (mesenchy-
mal cells in purple) suggest that they are direct targets of BMP signaling. At later stages of development, the expression of Bmp2 in the otic
capsule (salmon color in B) is proposed to be the main source of BMPs required for continued chondrocyte differentiation. In this model,
the level of BMPs in the otic capsule is regulated by Noggin (blue color in B). In addition, within the otic epithelium, BMPs act cell
autonomously for the growth and survival of the canal pouch, and continued growth and maintenance of the newly formed canal. The
expression pattern of Bmp2 suggests it plays a primary role in canal formation. However, the possible roles of BMP4 and -7, or various
heterodimer combinations of BMP2, -4, and -7, in canal formation require further investigation. It should be noted that the ubiquitous
expression of BMPRIA expression in otic epithelium and surrounding mesenchyme is not depicted in the schematics.
-
in cartilage overgrowth. However, injection of RCAS-
dnBMPRIA did not result in any apparent cartilage pheno-
type, which made it difficult to interpret the RCAS-
caBMPRIA results (data not shown). Also, the role of
BMPRIA cannot be addressed easily in a mouse model since
BMPRIA/ mice are early embryonic lethal (Mishina et al.,
1995, 2002; Tang et al., 1998), and further investigation will
require the generation of tissue-specific knockouts. There-
fore, multiple approaches in various animal models will be
required to decipher the complex roles of BMPs in the
development of the inner ear.
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